These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22413794)

  • 1. The scientific basis for establishing solubility criteria for veterinary species.
    Martinez MN; Fahmy R
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():81-6. PubMed ID: 22413794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug solubility classification in the dog.
    Martinez MN; Papich MG
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():87-91. PubMed ID: 22413795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug solubility classification in the bovine.
    Martinez MN; Apley MD
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():93-7. PubMed ID: 22413796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the electrokinetic properties on the stability of mebendazole suspensions for veterinary applications.
    Cózar-Bernal MJ; Gallardo V; Sáez-Fernández E; Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Arias JL
    Int J Pharm; 2010 Jun; 393(1-2):161-6. PubMed ID: 20435113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of fenbendazole suspensions for veterinary use. Correlation between zeta potential and sedimentation.
    Arias JL; López-Viota M; Clares B; Ruiz MA
    Eur J Pharm Sci; 2008 Aug; 34(4-5):257-62. PubMed ID: 18539013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.
    Martinez M; Amidon G; Clarke L; Jones WW; Mitra A; Riviere J
    Adv Drug Deliv Rev; 2002 Oct; 54(6):825-50. PubMed ID: 12363433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodology for phase selection of a weak basic drug candidate, utilizing kinetic solubility profiles in bio-relevant media.
    Furukawa S; Zhao C; Ohki Y
    Eur J Pharm Biopharm; 2010 Feb; 74(2):298-303. PubMed ID: 19815062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength.
    Alvarez-Lorenzo C; Gonzalez-Lopez J; Fernandez-Tarrio M; Sandez-Macho I; Concheiro A
    Eur J Pharm Biopharm; 2007 May; 66(2):244-52. PubMed ID: 17123799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution test development for complex veterinary dosage forms: oral boluses.
    Fahmy R; Marnane B; Bensley D; Hollenbeck RG
    AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Companion animal physiology and dosage form performance.
    Sutton SC
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents.
    Muela S; Escalera B; Peña MA; Bustamante P
    Int J Pharm; 2010 Jan; 384(1-2):93-9. PubMed ID: 19819314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for extrapolating in vivo bioequivalence data across species and routes.
    Modric S; Bermingham E; Heit M; Lainesse C; Thompson C
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():45-52. PubMed ID: 22413791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
    Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
    Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special series--use of pharmacokinetics in veterinary medicine. Article III: Physicochemical properties of pharmaceuticals.
    Martinez MN
    J Am Vet Med Assoc; 1998 Nov; 213(9):1274-7. PubMed ID: 9810382
    [No Abstract]   [Full Text] [Related]  

  • 15. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
    Dai WG; Pollock-Dove C; Dong LC; Li S
    Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of monovalent weak electrolytes by micellization or complexation.
    He Y; Yalkowsky SH
    Int J Pharm; 2006 May; 314(1):15-20. PubMed ID: 16580158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nicotinamide and urea on the solubility of riboflavin in various solvents.
    Coffman RE; Kildsig DO
    J Pharm Sci; 1996 Sep; 85(9):951-4. PubMed ID: 8877885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ideas about the solubility of drugs.
    Box K; Comer JE; Gravestock T; Stuart M
    Chem Biodivers; 2009 Nov; 6(11):1767-88. PubMed ID: 19937815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-solvent solubilization of some poorly-soluble antidiabetic drugs.
    Seedher N; Kanojia M
    Pharm Dev Technol; 2009; 14(2):185-92. PubMed ID: 19519190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.